Thursday, September 15, 2022 6:15:38 PM
Fact check:
These are the “types” that are posted on clinicaltrials.gov: “investigational” and “observational.” Either of these could be adaptive. To date, “adaptive” is not a distinct and separate “type” for any clinical trial in the U.S. in terms of the nature of studies as they are currently registered on the NIH clinical trial registry.
“Type”
describes the nature of a
clinical study. Study types
include interventional studies
(also called clinical trials),
and observational studies
(including patient registries)
and expanded access.
https://clinicaltrials.gov/ct2/about-studies/learn
https://virtualtrials.org/dcvax.cfm
These are the “types” that are posted on clinicaltrials.gov: “investigational” and “observational.” Either of these could be adaptive. To date, “adaptive” is not a distinct and separate “type” for any clinical trial in the U.S. in terms of the nature of studies as they are currently registered on the NIH clinical trial registry.
“Type”
describes the nature of a
clinical study. Study types
include interventional studies
(also called clinical trials),
and observational studies
(including patient registries)
and expanded access.
https://clinicaltrials.gov/ct2/about-studies/learn
https://virtualtrials.org/dcvax.cfm
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
